CNTN5

CNTN5 (NB-2) is a GPI-anchored immunoglobulin superfamily cell recognition molecule that functions in the development and maturation of glutamatergic synapses within central auditory circuits. It is preferentially expressed in glutamatergic neurons of the auditory brainstem, where it localizes to presynaptic membranes through a cis-complex with APLP1 and co-localizes with VGLUT1/VGLUT2-positive synapses including calyces of Held (PMID:19177518, PMID:22285261). CNTN5 promotes neurite outgrowth selectively from cortical neurons, and its genetic ablation in mice disrupts tonotopic organization and attenuates neural excitability in the inferior colliculus (PMID:11438979, PMID:12653969). Human iPSC-derived glutamatergic neurons carrying heterozygous de novo CNTN5 loss-of-function variants exhibit spontaneous network hyperactivity, linking CNTN5 haploinsufficiency to neuronal dysfunction in autism spectrum disorder (PMID:30747104).

1. 2000 Medium

   Cloning and chromosomal mapping of human CNTN5 established its genomic identity and brain expression pattern, revealing two splice isoforms and enrichment in amygdala and occipital lobe.

   Evidence cDNA cloning, FISH mapping to 11q21-q22.2, and RT-PCR across human brain regions

   PMID:11013081

   Open questions at the time

   • Single-lab characterization without independent replication
   • Functional significance of the two splice isoforms unknown
   • No mechanistic data on protein function
2. 2001 High

   Demonstration that CNTN5 promotes neurite outgrowth specifically from cortical neurons and is concentrated in auditory pathway nuclei answered what cell types respond to CNTN5 and where it acts in the brain.

   Evidence In vitro neurite outgrowth assays on cortical vs. hippocampal neurons; in situ hybridization and immunohistochemistry across brain regions

   PMID:11438979

   Open questions at the time

   • Receptor or signaling pathway mediating neurite outgrowth not identified
   • Basis for cortical vs. hippocampal selectivity unknown
3. 2003 High

   Knockout mouse studies revealed that CNTN5 loss disrupts auditory circuit function in vivo, establishing a causal role in tonotopic organization and neural excitability rather than merely correlative expression.

   Evidence NB-2-deficient mice (tau-LacZ knockin) assessed by audiogenic seizure testing and c-Fos immunohistochemistry in the inferior colliculus

   PMID:12653969

   Open questions at the time

   • Synaptic versus axon guidance mechanism not distinguished
   • Whether auditory phenotype reflects developmental or maintenance defect unclear
4. 2009 High

   Restriction of CNTN5 expression to glutamatergic neurons and its co-localization with glutamatergic synaptic markers refined the cellular context, implicating CNTN5 specifically in glutamatergic synapse maturation within auditory brainstem nuclei.

   Evidence Combined in situ hybridization and immunohistochemistry with VGLUT1, VGLUT2, and synapsin markers across developmental stages

   PMID:19177518

   Open questions at the time

   • Direct evidence that CNTN5 is required for glutamatergic synapse formation or function not yet provided
   • Trans-synaptic binding partners unknown
5. 2012 High

   Identification of APLP1 as a cis-interaction partner on presynaptic membranes provided the first molecular complex context for CNTN5, explaining how a GPI-anchored protein can be retained at synaptic sites.

   Evidence Pull-down and cell surface binding assays, immunofluorescence co-localization with synapsin, presynaptic fraction biochemical enrichment

   PMID:22285261

   Open questions at the time

   • Functional consequence of CNTN5-APLP1 interaction on synapse maturation not tested
   • Trans-synaptic ligands that the complex engages unknown
   • No structural data on the complex
6. 2019 High

   Human iPSC-derived neuron studies demonstrated that heterozygous CNTN5 loss-of-function causes network hyperactivity, directly connecting CNTN5 haploinsufficiency to a neuronal electrophysiological phenotype relevant to ASD.

   Evidence iPSC-derived glutamatergic neurons from individuals with de novo CNTN5 variants, multi-electrode array and patch-clamp recordings across multiple lines

   PMID:30747104

   Open questions at the time

   • Molecular pathway from CNTN5 loss to hyperactivity not delineated
   • Whether hyperactivity is excitatory/inhibitory imbalance or cell-autonomous not resolved
   • In vivo validation in human-relevant models pending

• The signaling pathway downstream of CNTN5, the identity of its trans-synaptic binding partners, and the mechanism by which CNTN5-APLP1 complexes regulate glutamatergic synapse maturation remain unresolved.
• No trans-synaptic ligand identified
• Intracellular signaling cascade unknown for a GPI-anchored molecule
• Structural basis of CNTN5-APLP1 interaction uncharacterized